Sanjum Sethi, MD
Interventional Cardiology · New York, NYNPI 1174783336
Payments from drug & device makers
Across 717 payments — averaging $837.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$135K
- Penumbra, Inc.$135K
- Inari Medical, Inc.$108K
- Johnson & Johnson$101K
- Terumo Medical Corporation$76K
- Angiodynamics, Inc.$23K
- plus $22K from 28 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 144 | $134,988 |
| Penumbra, Inc. | 64 | $134,640 |
| Inari Medical, Inc. | 143 | $107,700 |
| Johnson & Johnson | 119 | $101,372 |
| Terumo Medical Corporation | 32 | $76,409 |
| Angiodynamics, Inc. | 45 | $23,135 |
| Chiesi USA, Inc. | 16 | $11,312 |
| Argon Medical Devices, Inc. | 5 | $3,736 |
| Medtronic(2 entities) | 24 | $2,262 |
| Abbott | 7 | $916 |
| Cardiovascular Systems Inc. | 24 | $662 |
| Shockwave Medical, Inc | 9 | $549 |
| Novartis | 22 | $451 |
| Boehringer Ingelheim | 14 | $278 |
| Imperative Care, Inc | 3 | $249 |
| Cardiva Medical, Inc. | 3 | $248 |
| AstraZeneca | 7 | $233 |
| Edwards Lifesciences | 2 | $211 |
| Stryker | 3 | $197 |
| Abiomed | 2 | $169 |
| Cagent Vascular Inc | 4 | $145 |
| Philips North America LLC | 2 | $143 |
| E.r. Squibb & Sons, L.L.C. | 6 | $104 |
| Alnylam Pharmaceuticals Inc. | 2 | $61 |
| Amgen | 3 | $55 |
| Tactile Systems Technology Inc | 2 | $38 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $38 |
| Acist Medical Systems, Inc. | 1 | $34 |
| Endologix LLC | 1 | $30 |
| Pfizer | 1 | $29 |
| Cardinal Health 200 LLC | 2 | $25 |
| Heartflow, Inc. | 1 | $24 |
| Bridgebio Pharma, Inc. | 1 | $23 |
| Amarin Pharma, Inc. | 1 | $16 |
How this compares
$600,482 in reported general payments places this provider in the 90th percentile of 382 interventional cardiology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in New York
- Martin LeonNew York$13.5M
- Susheel KodaliNew York$6M
- Deepak BhattNew York$4.1M
- Samin SharmaNew York$3.7M
- Annapoorna KiniNew York$3.5M
- Sahil ParikhNew York$2.7M
- George DangasNew York$2.6M
- Prakash KrishnanNew York$2M
- Ajay KirtaneNew York$1.8M
- Shing-Chiu WongNew York$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.